Job Description
Job Description
Job Title: General Accountant
Position Summary:
The General Accountant is responsible for ensuring the accuracy and integrity of the financial records and operations. This role involves managing accounts payable, accounts receivable, preparing journal entries, reconciling accounts, responding to internal and external inquiries, supporting financial audits, and assisting in period-end closings. The ideal candidate is detail-oriented, organized, and comfortable working with accounting software and spreadsheets.
Key Responsibilities:
- Manage accounts payable, accounts receivable, and cash collection process as needed
- Prepare and post journal entries in the general ledger in a timely manner
- Reconcile bank statements and other financial accounts
- Maintain accurate financial records and documentation
- Assist in the preparation of monthly, quarterly, and annual financial and statutory reports, e.g., Form 1099 etc.
- Ensure compliance with accounting standards and internal controls under guidance
- Support internal and external audits by providing documentation, respond to internal and external inquiries
- Perform other related duties as assigned
Qualifications:
- Bachelor’s or associate degree in Accounting, Finance, or a related field
- 1–5 years of accounting experience
- Experienced in accounting software (e.g., QuickBooks) and Microsoft Excel
- Fully remote working experience and comfortable with the setting
Preferred Qualifications:
- Attention to detail and accuracy, flexible, able to work independently and willing to learn
- Organized, self-starter, and responsive
Company DescriptionRevalia Bio is seeking to revolutionize biomedical innovation by creating the world's first integrated human data stack
Revalia Bio is a forward-thinking digital health, tech startup building the world's first integrated human data stack to modernize biomedical innovation by enabling a new class of digitally enabled Phase 0 Human Trials.
Revalia’s Phase 0 Human Trial platform integrates various sources of human data to ask and answer questions that are impossible with current Phase I/II clinical trials or preclinical models alone. The key to the platform is Revalia’s ‘Human Organ Data Layer’ made possible by a unique network of partnerships assembled to support organ donation for research when those organs are not suitable for clinical transplant. The Revalia team brings those organs back to life on proprietary organ perfusion technology to create a ‘Rosetta Stone’ for human data that serves to integrate and contextualize all other sources of human data from patient medical records to cells in a petri dish.
Revalia provides access to the Phase 0 Human Trial through a Platform as a Service model that enables biomedical developers to design, track and interpret Phase 0 Human Trials at the click of a button guided by Rio, Revalia’s software companion. Through this new platform, Revalia aims to enable the global biomedical community—from academic scientists and hospitals to large biopharma—to effectively collaborate on creating better medicines faster. The team at Revalia believe that biomedical innovators should compete on delivering the best innovations to patients as fast as possible, not on access to critical human data.
Company Description
Revalia Bio is seeking to revolutionize biomedical innovation by creating the world's first integrated human data stack \r\n\r\nRevalia Bio is a forward-thinking digital health, tech startup building the world's first integrated human data stack to modernize biomedical innovation by enabling a new class of digitally enabled Phase 0 Human Trials. \r\n\r\nRevalia’s Phase 0 Human Trial platform integrates various sources of human data to ask and answer questions that are impossible with current Phase I/II clinical trials or preclinical models alone. The key to the platform is Revalia’s ‘Human Organ Data Layer’ made possible by a unique network of partnerships assembled to support organ donation for research when those organs are not suitable for clinical transplant. The Revalia team brings those organs back to life on proprietary organ perfusion technology to create a ‘Rosetta Stone’ for human data that serves to integrate and contextualize all other sources of human data from patient medical records to cells in a petri dish. \r\n\r\nRevalia provides access to the Phase 0 Human Trial through a Platform as a Service model that enables biomedical developers to design, track and interpret Phase 0 Human Trials at the click of a button guided by Rio, Revalia’s software companion. Through this new platform, Revalia aims to enable the global biomedical community—from academic scientists and hospitals to large biopharma—to effectively collaborate on creating better medicines faster. The team at Revalia believe that biomedical innovators should compete on delivering the best innovations to patients as fast as possible, not on access to critical human data.